Want to track KALA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Kala Pharmaceuticals, Inc. (KALA) Statistics
Valuation metrics
Market Cap 15.14M
Enterprise value 12.7M
Trailing P/E (ttm) -0.26
Forward P/E -0.39
PEG ratio -0
Price/Sales (ttm) -
Price/Book (mrq) 0.57
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.74
Overview
Shares outstanding 18.59M
Float 18.59M
Shares short 20.58K
% Held by insiders 0.01%
% Held by institutions 0.01%
Average volume (10 days) 68.61K
Average volume (90 days) 90.9K
Price summary
52-Week low 0.59
52-Week high 1,030
Beta -2.24
50-Day moving average 1.45
200-Day moving average 0.87
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:50
Last split Date 11 May 2026
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -1.6%
Return on equity -13.36%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -33.23M
Net income to common (ttm) -19.65M
Diluted EPS (ttm) -2.41
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 8.76M
Total cash per share (mrq) 1.08
Total debt (mrq) 29.94M
Total Debt/Equity (mrq) -3.46
Current ratio (mrq) 7.91%
Book value per share (mrq) 1.32
Cash Flow
Cash flow statement -26.06M
Levered free cash flow (LFCF) -19.47M
